等待开盘 08-25 09:30:00 美东时间
-0.190
-4.88%
Ci&T, Inc. (($CINT)) has held its Q2 earnings call. Read on for the main hi...
08-21 08:27
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从49美元升至56美元;韦德布什:维持Zura Bio"跑赢大市"评级,目标价从15美元升至22美元
08-13 11:44
UBS analyst Leonardo Olmos maintains CI&T (NYSE:CINT) with a Buy and lowers the price target from $7.2 to $6.2.
08-12 21:32
CI&T shares are trading lower after the company reported mixed Q2 financial results.
08-12 04:48
CI&T (NYSE:CINT) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.09 by 22.22 percent. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $142.820 million which beat...
08-12 04:16
CI&T (NYSE:CINT) raises FY2026 sales outlook from $555.800 million-$575.300 million to $565.500 million-$577.800 million vs $569.840 million estimate.
08-12 04:13
CI&T (NYSE:CINT) Q3 Revenue expected to be more than $145.700M vs $144.560M Est
08-12 04:12
今日重点评级关注:HC Wainwright & Co.:维持Greenwich LifeSciences"买入"评级,目标价从50美元升至69美元;高盛:维持Taysha Gene Therapies"买入"评级,目标价从11美元升至13美元
07-22 11:35
Wedbush analyst Steven Wahrhaftig downgrades CI&T (NYSE:CINT) from Outperform to Neutral and lowers the price target from $7 to $4.
07-21 21:29
全球AI部署合作伙伴CI&T本周宣布与法国开源AI模型公司Mistral建立多年期战略合作关系。根据协议,CI&T将作为Mistral在拉丁...
07-16 03:15